FDA Approved: IMATINIB MESYLATE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' imatinib mesylate as an original application for a generic version of the cancer drug, for the same indications as the brand-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

ORIG AP for IMATINIB MESYLATE (IMATINIB MESYLATE)